Cargando…

The prognostic capability of inflammatory proteins in predicting peripheral artery disease related adverse events

BACKGROUND: Levels of inflammatory proteins and their prognostic potential have been inadequately studied in patients with peripheral artery disease (PAD). In this study, we quantified and assessed the ability of inflammatory proteins in predicting PAD-related adverse events. METHODS: In this prospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ben, Djahanpour, Niousha, Zamzam, Abdelrahman, Syed, Muzammil H., Jain, Shubha, Arfan, Sara, Abdin, Rawand, Qadura, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792492/ https://www.ncbi.nlm.nih.gov/pubmed/36582735 http://dx.doi.org/10.3389/fcvm.2022.1073751

Ejemplares similares

Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

Angiogenesis-related proteins as biomarkers for peripheral artery disease
por: Li, Ben, et al.
Publicado: (2023)

Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

The Clinical Utility of D-Dimer and Prothrombin Fragment (F1+2) for Peripheral Artery Disease: A Prospective Study
por: Arfan, Sara, et al.
Publicado: (2022)

Plasma complement component C2: a potential biomarker for predicting abdominal aortic aneurysm related complications
por: Feridooni, Tiam, et al.
Publicado: (2022)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Khan, Hamzah, et al.
Publicado: (2022)

Urinary neutrophil gelatinase-associated lipocalin (NGAL) can potentially predict vascular complications and reliably risk stratify patients with peripheral arterial disease
por: Ehsan, Mehroz, et al.
Publicado: (2022)

MicroRNA Profile of Patients with Chronic Limb-Threatening Ischemia
por: Syed, Muzammil H., et al.
Publicado: (2020)

Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease
por: Azab, Sandi M., et al.
Publicado: (2020)

Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease
por: Zamzam, Abdelrahman, et al.
Publicado: (2021)

Fatty Acid Binding Protein 4—A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients
por: Zamzam, Abdelrahman, et al.
Publicado: (2020)

Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: A three-year prospective follow-up study
por: Zamzam, Abdelrahman, et al.
Publicado: (2022)

Fatty acid binding protein 3 is associated with peripheral arterial disease
por: Syed, Muzammil H., et al.
Publicado: (2020)

Plateletworks(®) as a Point-of-Care Test for ASA Non-Sensitivity
por: Khan, Hamzah, et al.
Publicado: (2021)

A Systematic Review of Interleukins as Diagnostic and Prognostic Biomarkers for Peripheral Artery Disease
por: Djahanpour, Niousha, et al.
Publicado: (2023)

Perceived Challenges to Routine Uptake of the Ankle Brachial Index within Primary Care Practice
por: Chiu, Lily Y. C., et al.
Publicado: (2021)

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease
por: Alsuwailem, Bader, et al.
Publicado: (2021)

Increasing Awareness for Peripheral Artery Disease through the Identification of Novel Biomarkers
por: Li, Ben, et al.
Publicado: (2023)

Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry
por: Khan, Hamzah, et al.
Publicado: (2020)

Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
por: Khan, Hamzah, et al.
Publicado: (2021)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

Prognostic Model to Predict Postoperative Adverse Events in Pediatric Patients With Aortic Coarctation
por: Gu, Yan, et al.
Publicado: (2021)

Prognostic impact of implantable cardioverter defibrillators and associated adverse events in patients with continuous flow left ventricular assist devices
por: Pausch, Jonas, et al.
Publicado: (2023)

The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
por: Li, Ben, et al.
Publicado: (2022)

Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching
por: Murugavel, Shamini, et al.
Publicado: (2018)

Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy
por: Khan, Hamzah, et al.
Publicado: (2022)

Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

The role of cardiac computed tomography in predicting adverse coronary events
por: Emfietzoglou, Maria, et al.
Publicado: (2022)

Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Lee, Jane J., et al.
Publicado: (2021)

Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Management of a Mycotic Aneurysm in a Patient with COVID-19: A Case Report
por: Syed, Muzammil H., et al.
Publicado: (2021)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Prognostic Value of Arm Circumference for Cardiac Damage and Major Adverse Cardiovascular Events: A Friend or a Foe? A 2-Year Follow-Up in the Northern Shanghai Study
por: Zheng, Yixing, et al.
Publicado: (2022)

Sequential Surgical Procedures in Vascular Surgery Patients Are Associated With Perioperative Adverse Cardiac Events
por: Janssen, Henrike, et al.
Publicado: (2020)

Multisystem immune-related adverse events due to toripalimab: Two cases-based review
por: Chen, Yanran, et al.
Publicado: (2022)

Advanced progress of the relationship between PCSK9 monoclonal antibodies and hyperglycemic adverse events
por: Zhang, Ruixing, et al.
Publicado: (2023)

Efficacy of prognostic nutrition index in combination with D-dimer in predicting postoperative clinical adverse events after acute type A aortic dissection: a single center retrospective study
por: Xie, Linfeng, et al.
Publicado: (2023)

Impact of late gadolinium enhancement extent, location, and pattern on ventricular tachycardia and major adverse cardiac events in patients with ischemic vs. non-ischemic cardiomyopathy
por: Tat, Emily, et al.
Publicado: (2022)

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_077c8hukvil33rp89e9gbgq984